Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach
Top Cited Papers
- 10 January 2018
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 29 (3), 759-774
- https://doi.org/10.1681/asn.2017090958
Abstract
FSGS describes a renal histologic lesion with diverse causes and pathogenicities that are linked by podocyte injury and depletion. Subclasses of FSGS include primary, genetic, and secondary forms, the latter comprising maladaptive, viral, and drug-induced FSGS. Despite sharing certain clinical and histologic features, these subclasses differ noticeably in management and prognosis. Without an accepted nongenetic biomarker that discriminates among these FSGS types, classification of patients is often challenging. This review summarizes the clinical and histologic features, including the onset and severity of proteinuria as well as the presence of nephrotic syndrome, that may aid in identifying the specific FSGS subtype. The FSGS lesion is characterized by segmental sclerosis and must be differentiated from nonspecific focal global glomerulosclerosis. No light microscopic features are pathognomonic for a particular FSGS subcategory. The characteristics of podocyte foot process effacement on electron microscopy, while helpful in discriminating between primary and maladaptive FSGS, may be of little utility in detecting genetic forms of FSGS. When FSGS cannot be classified by clinicopathologic assessment, genetic analysis should be offered. Next generation DNA sequencing enables cost-effective screening of multiple genes simultaneously, but determining the pathogenicity of a detected genetic variant may be challenging. A more systematic evaluation of patients, as suggested herein, will likely improve therapeutic outcomes and the design of future trials in FSGS.Keywords
This publication has 71 references indexed in Scilit:
- Association of Histologic Variants in FSGS Clinical Trial with Presenting Features and OutcomesClinical Journal of the American Society of Nephrology, 2013
- Mutations in podocyte genes are a rare cause of primary FSGS associated with ESRD in adult patientsClinical Nephrology, 2012
- Clinical Utility of Genetic Testing in Children and Adults with Steroid-Resistant Nephrotic SyndromeClinical Journal of the American Society of Nephrology, 2011
- Mutations in the formin gene INF2 cause focal segmental glomerulosclerosisNature Genetics, 2009
- Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS)Nephrology Dialysis Transplantation, 2009
- Patients with ACTN4 Mutations Demonstrate Distinctive Features of Glomerular InjuryJournal of the American Society of Nephrology, 2009
- Drug-induced glomerulopathiesExpert Opinion on Drug Safety, 2005
- Evolution of nephrotic-associated focal segmental glomerulosclerosis and relation to the glomerular tip lesio11See Editorial by Haas,P. 1188.Kidney International, 2005
- Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltrationAmerican Journal of Kidney Diseases, 1999
- Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American Study of Kidney Disease (AASK) TrialKidney International, 1997